Key facts
- This page summarizes BioStar Ventures III, L.P.'s Form 3 filing for Autonomix Medical, Inc. (AMIX).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 01 Feb 2024, 16:41.
BioStar Ventures III, L.P. - 26 Jan 2024 Form 3 Insider Report for Autonomix Medical, Inc. (AMIX)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- AMIX
- Reported as of
- 26 Jan 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 01 Feb 2024, 16:41:16 UTC
- Next SEC filing
- 20 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Louis Cannon, MD, Founder, Senior Managing Director of the General Partner, BioStar Ventures III, L.L.C.
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
BioStar Ventures III, L.P. filed Form 3 for Autonomix Medical, Inc. (AMIX) on 01 Feb 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AMIX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,416,305
- Date
- 26 Jan 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.